citric acid, anhydrous has been researched along with Lupus Erythematosus, Systemic in 6 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "She was diagnosed with Systemic Lupus erythematosus (SLE) and Sjogren's syndrome and was started on mycophenalate mofetil." | 1.91 | Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases. ( Clark, BA; Manzi, S; Osman, O; Wasko, MC, 2023) |
| "Metabolic alkalosis is a common complication in TTP patients treated by frequent PP, but several factors that affect metabolic status may aggravate the alkalosis and induce uncompensated alkalosis." | 1.35 | A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura. ( Itabashi, M; Mizutani, M; Nagai, Y; Nitta, K; Ogawa, T; Tsuchiya, K; Yumura, W, 2008) |
| "We report a patient with systemic lupus erythematosus (SLE), who had developed metabolic alkalosis during plasmapheresis." | 1.29 | Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus. ( Bang, BK; Chang, YS; Choi, EJ; Choi, MY; Lee, JD; Lee, SH; Park, IS; Woo, JY, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Osman, O | 1 |
| Manzi, S | 1 |
| Wasko, MC | 1 |
| Clark, BA | 1 |
| Romick-Rosendale, LE | 1 |
| Brunner, HI | 1 |
| Bennett, MR | 1 |
| Mina, R | 1 |
| Nelson, S | 1 |
| Petri, M | 1 |
| Kiani, A | 1 |
| Devarajan, P | 1 |
| Kennedy, MA | 1 |
| Nagai, Y | 1 |
| Itabashi, M | 1 |
| Mizutani, M | 1 |
| Ogawa, T | 1 |
| Yumura, W | 1 |
| Tsuchiya, K | 1 |
| Nitta, K | 1 |
| Kao, CH | 1 |
| Lin, HT | 1 |
| Yu, SL | 1 |
| Wang, SJ | 1 |
| Lan, JL | 1 |
| Choi, MY | 1 |
| Lee, JD | 1 |
| Lee, SH | 1 |
| Park, IS | 1 |
| Woo, JY | 1 |
| Choi, EJ | 1 |
| Chang, YS | 1 |
| Bang, BK | 1 |
| Jolles, PR | 1 |
| Tatum, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proteomics Combined With Metabolomics Studies on the Efficacy of Telitacicept in Chinese Patients of Systemic Lupus Erythematosus[NCT05666336] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citric acid, anhydrous and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Lung inflammation in patients with systemic lupus erythematosus detected by quantitative 67Ga-citrate lung scanning.
Topics: Adult; Citrates; Citric Acid; Female; Gallium Radioisotopes; Humans; Inflammation; Lung; Lupus Eryth | 1994 |
5 other studies available for citric acid, anhydrous and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases.
Topics: Adult; Arthritis, Rheumatoid; Calcium; Citric Acid; Female; Humans; Kidney Calculi; Lupus Erythemato | 2023 |
Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Topics: Citric Acid; Diagnosis, Differential; Female; Glomerulonephritis, Membranoproliferative; Glomerulone | 2011 |
A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura.
Topics: Adult; Alkalosis; Anticoagulants; Citric Acid; Cyclophosphamide; Female; Glucocorticoids; Humans; Im | 2008 |
Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus.
Topics: Adolescent; Alkalosis; Citrates; Citric Acid; Female; Humans; Lupus Erythematosus, Systemic; Plasmap | 1993 |
SLE myocarditis. Detection by Ga-67 citrate scintigraphy.
Topics: Citric Acid; Electrocardiography; Female; Gallium Radioisotopes; Heart; Humans; Lupus Erythematosus, | 1996 |